Download Adenosine - Wellington ICU

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Drug interaction wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Nicotinic agonist wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Psychopharmacology wikipedia , lookup

Theralizumab wikipedia , lookup

Bilastine wikipedia , lookup

Neuropharmacology wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Transcript
Adenosine
3/11/10
Part I Notes
PY Drug Book
Class
- short acting anti-arrhythmic
- naturally occurring purine nucleoside
Mechanism of Action
- depression of SA & AV nodal activity
- antagonises cAMP-mediated catecholamine stimulation of ventricular muscle
-> negative chronotropy & dromotropy
- direct agonist at specific cell membrane receptors (A1 & A2)
- A1 = coupled to K+ channels by a guanine nucleotide-binding protein in supraventricular
tissue.
Pharmaceutics
- clear, colourless
- 3mg/mL
- in saline
Dose
- rapid IV bolus followed by saline flush
- 3mg -> 6mg -> 12mg (adult)
- 0.04 to 0.25mg/kg (children)
Onset - 10 seconds
Duration - 10 seconds
Indications - diagnosis and treatment of paroxysmal SVT
Adverse Effects
-
bronchospasm
flushing
SOB
chest pain
Contraindications
- second and third degree AV block
Jeremy Fernando (2011)
- allergy
- care with asthma and COPD
PK
Absorption – must be given IV
Distribution
Metabolism – absorbed by RBC’s and endothelium
Elimination – t ½ = 10 seconds
Evidence
Jeremy Fernando (2011)